Replimune Group Inc (REPL)
7.90
-0.46
(-5.56%)
USD |
NASDAQ |
Jun 17, 15:49
Replimune Group Total Assets (Quarterly): 487.72M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 487.72M |
December 31, 2023 | 532.93M |
September 30, 2023 | 562.40M |
June 30, 2023 | 603.89M |
March 31, 2023 | 646.59M |
December 31, 2022 | 678.55M |
September 30, 2022 | 436.10M |
June 30, 2022 | 459.43M |
March 31, 2022 | 461.19M |
December 31, 2021 | 485.28M |
September 30, 2021 | 503.46M |
June 30, 2021 | 523.72M |
March 31, 2021 | 543.10M |
Date | Value |
---|---|
December 31, 2020 | 559.20M |
September 30, 2020 | 314.24M |
June 30, 2020 | 329.58M |
March 31, 2020 | 234.10M |
December 31, 2019 | 250.42M |
September 30, 2019 | 151.44M |
June 30, 2019 | 143.54M |
March 31, 2019 | 154.33M |
December 31, 2018 | 152.19M |
September 30, 2018 | 153.82M |
June 30, 2018 | 59.29M |
March 31, 2018 | 65.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
143.54M
Minimum
Jun 2019
678.55M
Maximum
Dec 2022
445.34M
Average
486.50M
Median
Total Assets (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 652.68M |
NovaBay Pharmaceuticals Inc | 5.357M |
Palatin Technologies Inc | 11.41M |
iBio Inc | 50.15M |
Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 113.21M |
Shareholders Equity (Quarterly) | 374.51M |